Our Spring 2022 newsletter commemorates Older Americans Month. Learn more about healthy aging and the connection to Alzheimer’s and dementia. Get tips on how to stay healthy as you age, news about upcoming events, and helpful resources. Read more by clicking the link below.
Volume 3, Issue 2: Spring 2022
In honor of National Diabetes Month, the Fall 2021 Newsletter is chock full of information on managing diabetes to help sustain brain health. Get news about Alzheimer’s.gov which is now available in Spanish, learn about upcoming events, and find helpful tools and resources. Read more by clicking the link below.
Read the Summer 2021 Newsletter to get updates on the Alzheimer’s Association International Conference, news about research on pollution and brain conditions, upcoming events, and tools you can use. Learn more by clicking the link below.
Volume 2, Issue 3: Summer 2021
November is National Diabetes Month in the United States. Many people don’t know that having diabetes can put your brain health at risk. Diabetes can damage blood vessels, which results in reduced or blocked blood flow to the brain. This can increase your risks for Alzheimer’s disease, memory loss, and confusion.
The Centers for Disease Control (CDC) has useful tips and resources to help manage blood sugar and protect your brain health. Many resources, including the flyer Healthy Blood Sugar, Healthy Brain, are available in both English and Spanish versions.
Language sample analysis may help predict future Alzheimer’s disease in people who are cognitively normal, suggesting that language patterns may be an early, detectable biomarker for the disease. Published in EClinicalMedicine, researchers at IBM Thomas J. Watson Research Center and Pfizer Worldwide Research and Development analyzed written language samples and were able to predict Alzheimer’s disease more than seven years before the diagnosis.
For the first time in almost 18 years, the U.S. Food and Drug Administration (FDA) has approved a new treatment — Aduhelm, also known as aducanumab — for Alzheimer’s disease, and a first targeted treatment for patients. With this approval, Aduhelm becomes the first disease-modifying therapy for Alzheimer’s, and the first such therapy to come under FDA review.
Common symptoms of dementia, including memory and cognitive problems, can lead people with dementia to have trouble handling money and paying bills. Repeated financial mistakes can be an early sign of the disease. Scientists at Johns Hopkins University linked Medicare claims data to credit card payments and credit reports to examine dementia-related money problems.
B. Smith was a restaurateur and lifestyle icon who openly shared her journey with early-stage Alzheimer’s disease. Smith died February 22nd at the age of 70.
The Alzheimer’s Association has shared tips for caregivers of people living with dementia who are both at home and in facilities during the coronavirus pandemic.
North Carolina Health News shares the story of members of a person-to-person support group for caregivers in Chapel Hill.
